Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA GMP Quality Metrics Will Be Industry’s ‘SAT Score’

This article was originally published in PharmAsia News

Executive Summary

Number 2 pencils will not be required, but the U.S. FDA hopes manufacturing reports will make purchasing decisions resemble the college admissions process to some extent.

You may also be interested in...



FDA’s Plaisier: GMP Oversight Must Shift To Outcomes Model

In an interview with “The Pink Sheet,” the Office of Regulatory Affairs chief says she wants to chart her office’s activities based on their effect on public health instead of simply counting outputs like the number of inspections or 483s.

Compounding: Hamburg Asks Purchasers, States To Push Outsourcer Registration

Letters seek help encouraging large-scale compounders to register with the agency as outsourcing facilities; FDA also seeks nominations for its compounding advisory committee.

Califf Laments Shift To Ex-US Clinical Trials – As Well As Pace Of Reforms At Home

US FDA commissioner tells J.P. Morgan conference that the agency, industry, and the entire healthcare system need to change ‘at the same time’ in order for clinical trials to improve.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC086121

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel